CBIS News and Events

News & Events

With Deep Learning Algorithms, Standard CT Technology Produces Spectral Images

Bioimaging technologies are the eyes that allow doctors to see inside the body in order to diagnose, treat, and monitor disease.

Rensselaer, GE Research, Cleerly, and Cornell Partner With NIH To Improve Cardiac CT Diagnosis

Heart disease is the leading cause of death worldwide for men and women. The most common type of heart disease, coronary artery disease, is caused when plaque builds up along the walls of arteries that carry blood to the heart. It is often diagnosed through a cardiac computed tomography (CT) scan, which shows doctors if arteries are narrowing.

A Better Carbon Trap Will Take Greenhouse Gases Out of the Air and Put Them To Use

Carbon capture technologies play a critical role in reducing greenhouse gas emissions from power plants and factories, while harnessing carbon dioxide (CO2) for other energy production.

With the support of a grant from the Department of Energy, Miao Yu, the Priti and Mukesh Chatter ’82 Career Development Chair of Chemical and Biological Engineering at Rensselaer Polytechnic Institute, will develop a novel porous material capable of capturing even very small concentrations of CO2 in the air and collecting the gas for further use

Physiological Test for Autism Proves Effective Independent of Co-occurring Conditions

TROY, N.Y. — Developing a physiological test for diagnosing autism spectrum disorder (ASD), one that measures certain components in the blood, has the potential to be a paradigm shift for diagnosing ASD. However, the large heterogeneity of how ASD affects individuals has long been viewed as a key obstacle to the development of such a test.

NIH Grant Supports Development of AI Tools To Identify High-Risk COVID-19 Patients

TROY, N.Y. — With COVID-19 still spreading in the United States, where it has already killed more than 140,000 people, improved screening and treatment options are critically important for high-risk patients with comorbidities, such as diabetes, pulmonary disease, and cardiovascular disease.

In Cell Studies, Seaweed Extract Outperforms Remdesivir in Blocking COVID-19 Virus

In a test of antiviral effectiveness against the virus that causes COVID-19, an extract from edible seaweeds substantially outperformed remdesivir, the current standard antiviral used to combat the disease.

Common FDA-Approved Drug May Effectively Neutralize Virus That Causes COVID-19

A common drug, already approved by the Food and Drug Administration (FDA), may also be a powerful tool in fighting COVID-19, according to research published this week in Antiviral Research.

Protein Linked to Cancer Acts as a Viscous Glue in Cell Division

New research, published online today in Developmental Cell, shows that PRC1 – a protein that serves as a telltale sign in many cancer types, including prostate, ovarian, and breast cancer – acts as a “viscous glue” during cell division, precisely controlling the speed at which two sets of DNA are separated as a single cell divides.

Designer Peptides Show Potential for Blocking Viruses, Encourage Future Study

TROY, N.Y. — Chemically engineered peptides, designed and developed by a team of researchers at Rensselaer Polytechnic Institute, could prove valuable in the battle against some of the most persistent human health challenges.

CAREER Award Supports Research to Deepen Understanding of Osteoarthritis

TROY, N.Y. — Osteoarthritis is the most common type of arthritis, affecting more than 32.5 million adults in the United States. The key to preventing or even reversing its painful and debilitating effects may be uncovered through a better understanding of the biomechanics that influence a specific molecular component that is central to the body’s joints.

Unique System for Using UVC Light to Sterilize Masks in Bulk Developed at Rensselaer

TROY, N.Y. — The shortage of critical personal protective equipment (PPE) has been a persistent problem for medical and other front-line workers as they battle the COVID-19 pandemic at close range day after day. A team of researchers at Rensselaer Polytechnic Institute has developed a potential solution: a machine that uses ultraviolet (UVC) light to sterilize thousands of protective masks each day, rendering them safe for reuse.

Pages